BriaCell Therapeutics Corp. (NASDAQ:BCTXW – Get Free Report) shot up 0.2% during mid-day trading on Monday . The stock traded as high as $0.10 and last traded at $0.12. 11,886 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 113,230 shares. The stock had previously closed at $0.12.
BriaCell Therapeutics Price Performance
The firm has a fifty day moving average of $0.26 and a 200-day moving average of $0.27.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.
Further Reading
- Five stocks we like better than BriaCell Therapeutics
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- What is a Secondary Public Offering? What Investors Need to Know
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
